Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $6.48 million. The enterprise value is $1.28 million.

Market Cap	6.48M
Enterprise Value	1.28M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

APVO has 3.29 million shares outstanding.

Current Share Class	3.29M
Shares Outstanding	3.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+912.23%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.03%
Float	3.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.01
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.65.

Current Ratio	2.27
Quick Ratio	1.92
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -437.34% and return on invested capital (ROIC) is -145.20%.

Return on Equity (ROE)	-437.34%
Return on Assets (ROA)	-99.45%
Return on Invested Capital (ROIC)	-145.20%
Return on Capital Employed (ROCE)	-226.41%
Revenue Per Employee	n/a
Profits Per Employee	-$649,324
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.37% in the last 52 weeks. The beta is 5.63, so APVO's price volatility has been higher than the market average.

Beta (5Y)	5.63
52-Week Price Change	-99.37%
50-Day Moving Average	3.17
200-Day Moving Average	62.53
Relative Strength Index (RSI)	28.55
Average Volume (20 Days)	132,047

Short Selling Information

The latest short interest is 67,862, so 2.06% of the outstanding shares have been sold short.

Short Interest	67,862
Short Previous Month	160,711
Short % of Shares Out	2.06%
Short % of Float	1.83%
Short Ratio (days to cover)	0.40

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.30M
Pretax Income	-24.95M
Net Income	-24.03M
EBITDA	-24.04M
EBIT	-24.30M
Earnings Per Share (EPS)	-$110.78

Balance Sheet

The company has $9.41 million in cash and $4.21 million in debt, giving a net cash position of $5.20 million or $1.58 per share.

Cash & Cash Equivalents	9.41M
Total Debt	4.21M
Net Cash	5.20M
Net Cash Per Share	$1.58
Equity (Book Value)	6.52M
Book Value Per Share	2.02
Working Capital	6.19M

Cash Flow

Operating Cash Flow	-24.65M
Capital Expenditures	n/a
Free Cash Flow	-24.65M
FCF Per Share	-$7.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-370.92%
FCF Yield	-380.55%

Analyst Forecast

The average price target for APVO is $5,920.00, which is 300,407.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5,920.00
Price Target Difference	300,407.61%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 27, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	May 27, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1